Eli Lilly (LLY) reported Q4 non-GAAP earnings Thursday of $5.32 per diluted share, up from $2.49 a year earlier.
Analysts polled by FactSet expected $5.01.
Revenue for the quarter ended Dec. 31 was $13.53 billion, up from $$9.35 billion a year earlier.
Analysts surveyed by FactSet expected $13.53 billion.
For 2025, the company said it expects non-GAAP EPS of $22.50 to $24 on revenue of $58 billion to $61 billion.
Analysts polled by FactSet expect non-GAAP EPS of $22.76 on $58.77 billion in revenue.
The company's shares were up nearly 3% in recent Thursday premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。